Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial

NCT06657079 is registered in ClinicalTrials.gov with Damanhour University as lead sponsor.

NCT NCT06657079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combination of an Inhaled Budesonide and Ipratropium in Patients at Risk of Developing Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial
Lead sponsor
Damanhour University
Phase
Phase 1/2
Overall status
Completed
Start date
May 1, 2024
Completion date
January 1, 2025
Enrollment
119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards, prevention and control